Font Size:
a
A
A
Keyword [3A cells]
Result: 1 - 18 | Page: 1 of 1
1.
Comparative Study On 2D Or 3D Cultured Rat Primary Hepatocytes And BRL-3A Cells In The Evaluation Of Drug Induced Hepatotoxicity
2.
Study On The Mechanism Of The Inhibition Of BRL-3A Cells Sirtuin 1 Activity Induced By Methylglyoxal
3.
The Role And Mechanism Of DMKG In The Activation Of HSC And Liver Fibrosis
4.
Protective Effects Of JZT And OA-Encapsulated Chitosan Nanoparticles On Palmitic Acid-Induced Insulin Resistance In BRL-3A Cells
5.
Exendin-4 Resists The Lipotoxicity Of Palmitic Acid On BRL 3A Cells And Influences The Expression Of MKK4/7 And P-JNK
6.
Pinocembrin Alleviates Hypoxia Reoxygenation Injury In BRL-3A Cells
7.
Protective Effects Of Astragalus Essential Components Against BRL-3A Cells Oxidative Stress
8.
Protective Effects Of Quercetin To Aflatoxin B
1
-Induced Cytotoxicity In BRL-3A Cells
9.
Screening Of Copper Chelating Capacity Of Anti-HLD Drugs And Evaluation Of Its Decoppering Activity
10.
A comparison of endocytic processes in untransfected and transfected Madin-Darby canine kidney cells expressing human growth hormone
11.
Study On The Mechanism Of Arsenic Trioxide Inducing Hepatotoxicity Through Thyroid Hormone Receptor ?
1
-mediated Thyroid Hormone Signaling Pathway
12.
Studies On The Application Of MiR-155-3p To Regulate The Proliferation Of Rat Hepatocytes And Liver Regeneration
13.
The Protective Effect And Mechanism Of Short-term Low-concentration H
2
O
2
Treatment Involving ROS-JNK Pathway On BRL-3A Cells
14.
Study On The Mechanism Of MiR-193b-5p Regulating Acrylamide-induced Cell Cycle And Cell Proliferation In Rat BRL-3A Cells By Targeting FoxO3
15.
Study On The Role Of NF-?B/miR-21/PDCD4 Pathway In Arsenic-induced Inflammatory Injury Of BRL-3A Cells
16.
Preliminary Study On The Protective Effect And Mechanism Of Maslinic Acid On H
2
O
2
-induced Oxidative Injury In BRL-3A Cells
17.
Study On The Mechanism Of Curcumin Protecting Copper-injured HLD Model Cells Through Inhibiting Ferroptosis
18.
Protective Effect And Its Mechanism Of Angiotensin Converting Enzyme 2 (ACE2) In Nonalcoholic Fatty Liver Disease (NAFLD)
<<First
<Prev Next>
Last>>
Jump to